Gland Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1772.30

-5.30 (-0.30%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1772.30

-5.30 (-0.30%)
16:02 Dec 20

Quality

46/100
Medium Financial Strength

Valuation

35/100
Mid Valuation

Technical

41/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	3462.88	4400.71	3624.6	5664.72	5890.15
Operating Expenses +	2160.65	2890.55	2599.83	4331.65	4613.68
Raw Material	1765.36	2072.52	1732.34	2275.2	2008.6
Increase Decrease in Cost	-273.49	36.69	-46.92	127.88	329.75
Other Manufacturing Expense	74.58	95.05	124.84	0	213.82
Employee Cost	311.36	338.57	403.26	1256.89	1382.28
Miscellaneous Expenses	315.24	399.04	417.49	717.82	679.23
Operating Profit	1302.23	1510.16	1024.77	1333.07	1276.47
Other Income	134.78	223.94	240.46	170.24	190.63
Depreciation	98.78	110.3	146.74	344.57	383.74
Interest	3.41	5.24	7.45	26.2	26.97
Profit before tax and exceptio..	1334.81	1618.55	1111.04	1132.54	1056.39
Exceptional Items	0	0	-56.46	0	0
PBT	1334.81	1618.55	1054.58	1132.54	1056.39
Provision for Taxation	337.85	406.89	273.54	360.08	364.84
Net Profit	996.96	1211.66	781.04	772.46	691.57
NET Profit after MI	996.96	1211.66	781.04	772.46	691.57
EPS	62.99	73.81	47.43	46.9	41.99
Operating Profit Margin (%)	37.61	34.32	28.27	23.53	21.67
Net Profit Margin (%)	28.79	27.53	21.55	13.64	11.74

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	51.80	51.80	57.90	57.90	57.90
FII	4.50	6.90	3.60	4.00	4.90
MF	32.80	30.50	23.00	21.30	19.80
Public	8.30	8.50	13.30	13.90	14.80
Others	0.10	0.00	0.00	0.00	0.00
Others	2.50	2.30	2.20	2.90	2.60